ACCURAY INC stock forecast: up to 2.47 USD ARAY stock price prognosis

STOCK

Forecast for Thu 30 Mar 2023 price 2.62

ACCURAY INC stock price forecast for further price development up to 1.10% (time horizon: 1 day) and price target of 2.47 USD. Positive news sentiment. Short-term (time horizon: 2 weeks) ACCURAY INC share price prediction for 2023-03-30 with daily closed price projections

Key Facts

Symbol ARAY 

ISIN US0043971052 

CUSIP 004397105


Currency USD


Category Surgical & Medical Instruments & Apparatus

Forecast price change %


News sentiment (1.00)


News <--> Close correlation for next day influence (0.02)

Finance numbers

Revenue 380,330,000.0


Earnings per share 0.05


On our site we made daily predictions for finance products based on statistical analysis. You can export / download forecasted data as CSV file, no login required. The information can be used for day trading.

The forecast (dashed curve) of the share price performance is based on historical data. Our forecast model is based on mathematical, statistical methods. The website offers price forecasts and analysis tools for equities and other securities, which are exclusively based on the prices of these securities in the past. Information about these prices is provided to us by third parties. Although we believe, If we believe that our sources are reliable, we cannot guarantee the accuracy, completeness, timeliness and correct sequencing of this information. We do not investigate the issuers of the securities to which our forecasts relate, nor do we consider any financial data or other data of such issuers with the exception of the past prices of the securities. Therefore, our forecasts do not constitute an analysis of other commercial or financial factors or circumstances, that may be relevant for future security price flows. Investments require additional considerations. Our forecasts cannot reflect the specific situation. Experience and risk profile of an individual investor or the tax implications an investment may have for the investor. Although we believe that our mathematical models are a tool to try to explore the possibility for future price development with the help of past performance, such developments are subject to a multitude of different influences. and therefore not really predictable. We cannot guarantee the success of any investment you make based on the information published here. This website is for information purposes only. All information and data on this website cannot be guaranteed to be accurate, accuracy, completeness and appropriateness - neither explicit nor implicit.

Summerized Form 10-K with GPT-2

We were incorporated in California in 1990 and commenced operations in 1992. These limitations include: • Limited versatility and precision. We believe our current technologies and our future innovations can help to achieve this. Continue to innovate through clinical development and collaboration. The CyberKnife platform maximizes patient comfort. InTempo Adaptive Imaging System. Key capabilities of these options are as follows: TomoDirect Mode. TomoDirect is standard on the TomoTherapy HDA model and Radixact X7 and X9 models. Treatment delivery is quickly completed for each beam angle. It can manage users and privileges to control patient data access. Outside the United States, we market to customers directly and through distributors. In June 2016, we received 510(k) clearance for the Radixact Treatment Delivery Platform. Pre‑market approval (PMA) pathway. After a device is placed on the market, numerous regulatory requirements apply. Such data will be made available by the government on a publicly searchable website. We are also subject to federal and state physician self‑referral laws. Both the scope and exceptions for such laws vary from state to state. Additionally, our products are subject to regulations in China. 8226; We depend on key employees, the loss of whom would adversely affect our business. As of June 30, 2021, we had an accumulated deficit of $488.0 million. In the event we fail to achieve profitability, our stock price could decline. We have been, and anticipate in the future being subject to such 40 inspections. We depend on key employees, the loss of whom would adversely affect our business. We also expect that other participants will enter the field. Our liquidity could be adversely impacted by adverse conditions in the financial markets. Either process can be expensive, lengthy and unpredictable. 56 Laws and ethical rules governing interactions with healthcare providers.

Summerized Form 10-K with GPT-2 https://www.sec.gov/Archives/edgar/data/1138723/000156459021044920/0001564590-21-044920.txt
Candlestick patterns

Candlestick patterns can be used as additional information for price prediction. Following list show which pattern applies on latest price information.

  • Meta analyst score 43.40/100
    • Good financial position.
    • Historical view, profit is growing.
    • Company revenue is not growing faster compared with the industry.
    • Stock price is above book price value.

Institutional ownership list is based on filling form information

Fund ownership list is based on filling form information

Fund name Date Amount Profile
Fidelity Concord Street Trust 2021-05-31 143156 Long
Fidelity Salem Street Trust 2021-04-30 685934 Long
Fidelity Concord Street Trust 2021-04-30 16971 Long
PRIMECAP Odyssey Funds 2021-04-30 1231800 Long
iShares Trust 2021-04-30 18612 Long

Insider trading for ACCURAY INC

CIK Name Date Action T-Test 1day T-Test 7day T-Test 14day T-Test 30day
1756775 Chew Jesse 2022-11-01 SALE Accept Accept Accept Accept
1756773 Spine Patrick 2022-11-01 SALE Accept Accept Accept Accept
1405200 Winter Suzanne C 2022-11-01 SALE Accept Accept Accept Accept
1825890 Hoge Michael 2022-03-01 SALE Accept Accept Accept Accept

Bollinger Bollinger Bands for ACCURAY INC can provide the information where the market is moving based on price information.


ACCURAY INC Short Volume Ratio is shown in the diagram. Short volume sales can be seen as an investor sentiment.


On-Balance Volume information for ACCURAY INC. On-Balance Volume information can be an indicator for bullish or bearish outcome.


Accumulation / Distribution (A/D) indicator information for ACCURAY INC. The indicator identify divergences between price and volume flow.


Aroon Oscillator information for ACCURAY INC. The trend-following indicator can show the strengh of a current trend and likelihood that trend can continue.


Average Directional Index (ADX) information for ACCURAY INC. The index can be used to identify the strengh of a trend.


Moving Average Convergence Divergence (MACD) for ACCURAY INC. The indicator helps to predict trend direction and the momentum of the trend.


Stochastic Oscillator as momentum indicator for ACCURAY INC. The indicator is useful for identifying overbought and oversold levels.


Relative Strength Index (RSI) for ACCURAY INC. RSI is a momentum oscillator that measures the speed and change of price development. The momentum indicator was created by analyst Welles Wilder. The result compares recent gains and losses over restricted time period. Primary usage of the indicator is to identify overbought or oversold signals. When RSI indicator reaches a value of 70 it could mean that speculators should consider selling, suggests Wilder and Chong. Or vice versa when selling excess at which the RSI Indicators show a value of 30 [ Relative Strength Index for Developing Effective Trading Strategies in Constructing Optimal Portfolio ].


52W High 52W Low Market Cap

Similar shares


ACCURAY INC on Nasdaq

ACCURAY INC on finviz

Figure below show the stock predictions.
Date Closing price Prediction was updated
2023-02-07 2.47 2023-02-02 03:57
2023-02-08 2.47 2023-02-02 03:57
2023-02-10 2.48 2023-02-02 03:57
2023-02-15 2.49 2023-02-02 03:57
2023-02-16 2.50 2023-02-02 03:57
2023-02-20 2.52 2023-02-02 03:57
2023-02-21 2.52 2023-02-02 03:57
2023-02-22 2.53 2023-02-02 03:57
2023-02-23 2.53 2023-02-02 03:57
2023-02-03 2.47 2023-02-02 03:57
2023-02-06 2.47 2023-02-02 03:57
2023-02-09 2.47 2023-02-02 03:57
2023-02-13 2.51 2023-02-02 03:57
2023-02-14 2.50 2023-02-02 03:57
2023-02-17 2.52 2023-02-02 03:57
2023-02-24 2.53 2023-02-02 03:57
2023-02-27 2.54 2023-02-02 03:57
2023-02-28 2.54 2023-02-02 03:57
2023-03-01 2.55 2023-02-02 03:57
2023-03-02 2.55 2023-02-02 03:57
2023-03-06 2.56 2023-02-02 03:57
2023-03-03 2.55 2023-02-02 03:57
2023-03-07 2.56 2023-02-02 03:57
2023-03-08 2.56 2023-02-02 03:57
2023-03-09 2.57 2023-02-02 03:57
2023-03-10 2.57 2023-02-02 03:57
2023-03-13 2.57 2023-02-02 03:57
2023-03-14 2.58 2023-02-02 03:57
2023-03-15 2.58 2023-02-02 03:57
2023-03-16 2.59 2023-02-02 03:57
2023-03-17 2.59 2023-02-02 03:57
2023-03-20 2.59 2023-02-02 03:57
2023-03-21 2.60 2023-02-02 03:57
2023-03-22 2.60 2023-02-02 03:57
2023-03-23 2.61 2023-02-02 03:57
2023-03-24 2.61 2023-02-02 03:57
2023-03-27 2.61 2023-02-02 03:57
2023-03-28 2.61 2023-02-02 03:57
2023-03-29 2.62 2023-02-02 03:57
2023-03-30 2.62 2023-02-02 03:57